Aids: Part II

DeVita, 1987, Developmental therapeutics and the acquired immunodeficiency syndrome, Ann Intern Med, 106, 568, 10.7326/0003-4819-106-4-568 McQuade, 1990, A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-1 like particle maturation, Science, 247, 454, 10.1126/science.2405486 Pottage, 1990, Comparative in vitro anti-HIV activity of four new aminosugar derivatives, 185 Yarchoan, 1989, Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related didoxynucleotides, N Engl J Med, 321, 726, 10.1056/NEJM198909143211106 Broder, 1990, Antiretroviral therapy in AIDS, Ann Intern Med, 113, 604, 10.7326/0003-4819-113-8-604 Pizzo, 1988, Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection, N Engl J Med, 319, 889, 10.1056/NEJM198810063191401 Yarchoan, 1986, Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS and AIDS-related complex, Lancet, 1, 575, 10.1016/S0140-6736(86)92808-4 Creagh-Kirk, 1988, Survival experience among patients with AIDS receiving zidovudine: Follow up of patients in a compassionate plea program, JAMA, 260, 3009, 10.1001/jama.1988.03410200065027 Fischl, 1990, A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immuno-deficiency syndrome, N Engl J Med, 323, 1009, 10.1056/NEJM199010113231501 Collier, 1990, A pilot study of low dose zidovudine in human immunodeficiency virus infection, N Engl J Med, 323, 1015, 10.1056/NEJM199010113231502 Moore, 1991, Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease, Arch Intern Med, 151, 981, 10.1001/archinte.1991.00400050123023 Moore, 1991, Zidovudine and the natural history of the acquired immunodeficiency syndrome, N Engl J Med, 324, 1412, 10.1056/NEJM199105163242006 Schmitt, 1988, Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex, N Engl J Med, 319, 1573, 10.1056/NEJM198812153192404 Yarchoan, 1987, Response of human immunodeficiency virus-associated neurological disease to 3′-azido-3′-deoxythymidine, Lancet, 1, 132, 10.1016/S0140-6736(87)91968-4 Pottage, 1988, Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine, JAMA, 260, 3045, 10.1001/jama.1988.03410200101034 1988, Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV): A prospective study, Ann Intern Med, 109, 718, 10.7326/0003-4819-109-9-718 Richman, 1987, The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): A double-blind, placebo-controlled trial, N Engl J Med, 317, 192, 10.1056/NEJM198707233170402 Spivak, 1989, Serum immunoreactive erythropoietin in HIV infected patients, JAMA, 261, 3104, 10.1001/jama.1989.03420210052015 Fischl, 1990, Recombinant human erythropoietin for patients with AIDS treated with zidovudine, N Engl J Med, 322, 1488, 10.1056/NEJM199005243222103 Walker, 1988, Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi's sarcoma treated with zidovudine, Ann Inter Med, 108, 372, 10.7326/0003-4819-108-3-372 Rachlis, 1990, Zidovudine (retrovir) update, Can Med Assoc J, 143, 1177 Gertner, 1989, Zidovudine associated myopathy, Am J Med, 86, 814, 10.1016/0002-9343(89)90478-6 Dalakas, 1990, Mitochondrial myopathy caused by long-term zidovudine therapy, N Engl J Med, 322, 1098, 10.1056/NEJM199004193221602 Spear, 1988, Zidovudine over-dosage, Ann Intern Med, 109, 76, 10.7326/0003-4819-109-1-76 Edwards, 1990, Esophageal ulceration induced by zidovudine, Ann Intern Med, 112, 65, 10.7326/0003-4819-112-1-65 Dubin, 1989, Zidovudine induced hepatotoxicity, Ann Intern Med, 110, 85, 10.7326/0003-4819-110-1-85 Pluda, 1990, Development of non-Hodgkin's lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy, Ann Intern Med, 113, 276, 10.7326/0003-4819-113-4-276 Moore, 1991, Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine, JAMA, 265, 2208, 10.1001/jama.1991.03460170062034 Larder, 1989, HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy, Science, 243, 1731, 10.1126/science.2467383 Richman, 1990, Effect of stage of disease and drug dose on zidovudine susceptibilities on isolates of human immunodeficiency virus, J Acquir Immune Defic Syndr, 3, 743 Larder, 1989, Multiple mutations in HIV-1 reverse transcriptase confer high level resistance to zidovudine, Science, 246, 1155, 10.1126/science.2479983 Larder, 1990, Susceptibilities of zidovudine susceptible and resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay, Antimicrob Agents Chemother, 34, 436, 10.1128/AAC.34.3.436 Yarchoan, 1990, Long-term toxicity/activity profile of 2′,3′-dideoxyinosine in AIDS or AIDS-related complex, Lancet, 336, 526, 10.1016/0140-6736(90)92085-V Lambert, 1990, 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex—A phase I trial, N Engl J Med, 322, 1333, 10.1056/NEJM199005103221901 Cooley, 1990, Once daily administration of 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex—results of a phase I trial, N Engl J Med, 322, 134, 10.1056/NEJM199005103221902 Pottage, 1991, Experience with didanosine in patients with advanced AIDS and <100 CD4+ cells Fulton, 1991, Safety profile of ddI (2′,3′-dideoxyinosine): Results of the Canadian ddI treatment program Shay, 1991, The effects of didanosine (ddI) on patients with late stage HIV disease enrolled in expanded access protocols Steinberg, 1991, Outcome and toxicities on 2′,3′-dideoxyinosine in the expanded access program St Clair, 1991, Resistance to ddI and sensitivity to AZT reduced by a mutation in HIV-1 reverse transcriptase, Science, 253, 1557, 10.1126/science.1716788 Yarchoan, 1988, Phase I studied of 2′,3′-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT), Lancet, 1, 76, 10.1016/S0140-6736(88)90283-8 Merigan, 1989, Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections, Ann Intern Med, 110, 189, 10.7326/0003-4819-110-3-189 Merigan, 1990, Safety and tolerance of dideoxycytidine as a single agent, 88, 11S Skowron, 1990, Alternating and intermittent regimens of zidovudine (3′-azido-3′-deoxythymidine) and dideoxycytidine (2′,3′-dideoxycytidine) in the treatment of patients with AIDS and AIDS-related complex, Am J Med, 88, 20S, 10.1016/0002-9343(90)90417-C Skowron, 1990, Phase II trial of alternating and intermittent regimens of zidovudine (ZDV) and 2′,3′-dideoxycytidine (ddC) in ARC and AIDS Barditch-Crobo, 1991, Phase I pharmacokinetic evaluation of 3′-deoxy-3′-fluorothymidine (FLT), a new potent anti-HIV nucleoside Davey, 1991, L-697,639 and L-697,661 novel agents for treatment of human immunodeficiency virus type 1 infections Laskin, 1991, Human pharmacokinetics and tolerability of L-697,661 and L-697,639 non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors Althaus, 1991, Inhibition kinetics and binding characteristics of Norel Bisheteroary/piperazine inhibitors of HIV-1 reverse transcriptase DeWit, 1991, Pharmacokinetics of TIBO (R82913) in AIDS patients: A phase I study Krown, 1990, Interferon alpha with zidovudine, 112, 812 Fischl, 1991, Antiretroviral therapy in combination with interferon for AIDS-related Kaposi's sarcoma, Am J Med, 90, 2S, 10.1016/0002-9343(91)90404-L Surbone, 1988, Treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex with a regimen of 3′-azido-2′,3′-dideoxythymidime (azidothymidine or zidovudine) and acyclovir. A pilot study, Ann Intern Med, 108, 534, 10.7326/0003-4819-108-4-534 Hollander, 1989, Phase I study of low dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals, Am J Med, 87, 628, 10.1016/S0002-9343(89)80394-8 Fiddian, 1989, Preliminary report of multicenter study of zidovudine plus or minus acyclovir in patients with AIDS or ARC, J Infect, 18, 79, 10.1016/S0163-4453(89)80084-2 National Institute of Allergy and Infectious Diseases, 1990, State of the art conference on azidothymidine therapy for early HIV infection, Am J Med, 89, 335, 10.1016/0002-9343(90)90347-G Fauci, 1989, Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection, Ann Intern Med, 110, 373, 10.7326/0003-4819-110-5-373 Dolin, 1991, The safety and immunogenicity of a HIV-1 recombinant gp160 candidate vaccine in humans, Ann Intern Med, 114, 119, 10.7326/0003-4819-114-2-119 Redfield, 1991, HIV vaccine therapy: Phase I safety and immunogenicity evaluation of active immunization with recombinant gp160 Glatt, 1988, Treatment of infections associated with human immunodeficiency virus, N Engl J Med, 318, 1439, 10.1056/NEJM198806023182206 Kovacs, 1988, Pneumocystis carinii pneumonia: Therapy and prophylaxis, J Infect Dis, 158, 254, 10.1093/infdis/158.1.254 Montgomery, 1991, Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome, 127 Phair, 1990, The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1, N Engl J Med, 322, 161, 10.1056/NEJM199001183220304 Gerrard, 1987, Serological study of Pneumocystis carinii infection in the absence of immunosuppression, Arch Dis Child, 62, 177, 10.1136/adc.62.2.177 DeLorenzo, 1987, Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS, Chest, 91, 323, 10.1378/chest.91.3.323 Telzak, 1990, Extrapulmonary Pneumocystis carinii infections, Rev Infect Dis, 12, 380, 10.1093/clinids/12.3.380 Edelstein, 1990, Atypical presentations of Pneumocystis carinii pneumonia in patients receiving inhaled pentamidine prophylaxis, Chest, 98, 1366, 10.1378/chest.98.6.1366 Jules-Elysee, 1990, Aerosolized pentamidine: Effect on diagnosis and presentation of Pneumocystis carinii pneumonia, Ann Intern Med, 112, 750, 10.7326/0003-4819-112-10-750 Golden, 1986, Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia, 90, 18 Zaman, 1988, Rapid noninvasive diagnosis of Pneumocystis carinii from induced liquified sputum, Ann Intern Med, 109, 7, 10.7326/0003-4819-109-1-7 Sattler, 1988, Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome, 109, 281 Medina, 1990, Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome, 323, 776 Bozzette, 1990, A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome, N Engl J Med, 323, 1451, 10.1056/NEJM199011223232104 Gagnon, 1990, Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome, 323, 1444 The, 1990, Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome, N Engl J Med, 323, 1500, 10.1056/NEJM199011223232131 Black, 1991, Clindamycin and primaquine as primary treatment for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS, Eur J Clin Microbiol Infect Dis, 10, 204, 10.1007/BF01964465 Conte, 1990, Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS, 113, 203 SooHoo, 1990, Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS, 113, 195 Allegra, 1987, Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome, N Engl J Med, 317, 978, 10.1056/NEJM198710153171602 Sattler, 1990, Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumonia, J Infect Dis, 161, 91, 10.1093/infdis/161.1.91 Hughes, 1991, Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii: A phase I study in human immunodeficiency virus (HIV)-infected men, J Infect Dis, 163, 843, 10.1093/infdis/163.4.843 Centers for Disease Control, 1989, Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus, MMWR, 38, 1 Fischl, 1988, Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS, JAMA, 259, 1185, 10.1001/jama.259.8.1185 Leoung, 1990, Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia, 323, 769 Montaner, 1991, Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia, 114, 948 Kemper, 1990, Low dose dapsone prophylaxis of Pneumcystis carinii pneumonia in AIDS and AIDS-related complex, AIDS, 4, 1145, 10.1097/00002030-199011000-00015 Hirschel, 1991, A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia, N Engl J Med, 324, 1079, 10.1056/NEJM199104183241602 Wormser, 1991, Low dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection, Arch Intern Med, 151, 688, 10.1001/archinte.1991.00400040042010 Sha, 1991, Pneumocystis carinii choroiditis in patients with AIDS: Clinical features, response to therapy, and outcome, 285 National Institute of Allergy and Infectious Diseases, Division of AIDS, 1991 McCabe, 1987, Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy, Rev Infect Dis, 9, 754, 10.1093/clinids/9.4.754 Wong, 1984, Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers, Ann Intern Med, 100, 36, 10.7326/0003-4819-100-1-36 Luft, 1988, Toxoplasmic encephalitis, J Infect Dis, 157, 1, 10.1093/infdis/157.1.1 Navia, 1986, Cerebral toxoplasmosis complicating the acquired immunodeficiency syndrome: Clinical and neuropathological findings in 27 patients, Ann Neurol, 19, 224, 10.1002/ana.410190303 Haverkos, 1987, Assessment of therapy for toxoplasma encephalitis, Am J Med, 82, 907, 10.1016/0002-9343(87)90151-3 Cohn, 1989, Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome, Am J Med, 86, 521, 10.1016/0002-9343(89)90378-1 Leport, 1988, Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome: Efficacy of long term continuous therapy, Am J Med, 84, 94, 10.1016/0002-9343(88)90014-9 Dannemann, 1991, Treatment of acute toxoplasmosis with intravenous clindamycin, Eur J Clin Microbiol Infect Dis, 10, 193, 10.1007/BF01964461 Katlama, 1991, Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS, Eur J Clin Microbiol Infect Dis, 10, 189, 10.1007/BF01964459 Arujo, 1988, Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii, Antimicrob Agents Chemother, 32, 755, 10.1128/AAC.32.5.755 Fernandez-Martin, 1991, Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS, Antimicrob Agents Chemother, 35, 2049, 10.1128/AAC.35.10.2049 Araujo, 1991, Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii, Antimicrob Agents Chemother, 35, 293, 10.1128/AAC.35.2.293 Rolston, 1990, Cryptosporidiosis in patients with the acquired immunodeficiency syndrome, AIDS Med Rep, 3, 13 Soave, 1986, Cryptosporidium and cryptosporidiosis, Rev Infect Dis, 8, 1012, 10.1093/clinids/8.6.1012 Soave, 1988, Cryptosporidium and Isospora belli infections, J Infect Dis, 157, 225, 10.1093/infdis/157.2.225 Cello, 1989, Acquired immunodeficiency syndrome cholangiopathy: Spectrum of disease, Am J Med, 86, 539, 10.1016/0002-9343(89)90381-1 Menichetti, 1991, Diclazuril for cryptosporidiosis in AIDS, Am J Med, 90, 271, 10.1016/0002-9343(91)80174-K Kreinik, 1991, Successful management of intractable cryptosporidial diarrhea with intravenous octreotide, a somatostatin analogue, AIDS, 5, 765, 10.1097/00002030-199106000-00020 DeHovitz, 1986, Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome, N Engl J Med, 315, 87, 10.1056/NEJM198607103150203 Pape, 1989, Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome, N Engl J Med, 320, 1044, 10.1056/NEJM198904203201604 Smith, 1988, Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS): Etiology and response to therapy, Ann Intern Med, 108, 328, 10.7326/0003-4819-108-3-328 Berenguer, 1989, Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV), Ann Intern Med, 111, 129, 10.7326/0003-4819-111-2-129 Rosenthal, 1988, Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome, Am J Med, 84, 307, 10.1016/0002-9343(88)90430-5 Maayan, 1987, Strongyloides stercoralis hyper-infection in a patient with the acquired immunodeficiency syndrome, Am J Med, 83, 945, 10.1016/0002-9343(87)90656-5 Ledford, 1985, Microsporidiosis myositis in a patient with the acquired immunodeficiency syndrome, Ann Intern Med, 102, 628, 10.7326/0003-4819-102-5-628 Terada, 1987, Microsporidan hepatitis in the acquired immunodeficiency syndrome, Ann Intern Med, 107, 61, 10.7326/0003-4819-107-1-61 Centers for Disease Control, 1990, Microsporidian keratoconjunctivitis in patients with AIDS, MMWR, 39, 188 Krech, 1973, Complement-fixing antibodies against cytomegalovirus in different parts of the world, Bull World Health Organ, 49, 103 Ho, 1990, Cytomegalovirus, 1159 Jacobson, 1988, Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS), 108, 585 Drew, 1988, Cytomegalovirus infection in patients with AIDS, J Infect Dis, 158, 449, 10.1093/infdis/158.2.449 Bloom, 1988, The diagnosis of cytomegalovirus retinitis, Ann Intern Med, 109, 963, 10.7326/0003-4819-109-12-963 Dieterich, 1988, Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS, Rev Infect Dis, 10, S532, 10.1093/clinids/10.Supplement_3.S532 Dieterich, 1989, Cytomegalovirus colitis in AIDS: Presentation in 33 patients, 241 Theise, 1991, Cytomegalovirus esophagitis in AIDS: Diagnosis by endoscopic biopsy, Am J Gastroenterol, 86, 1123 Schneiderman, 1987, Papillary stenosis and sclerosing cholangitis in patients with the acquired immunodeficiency syndrome, Ann Intern Med, 106, 546, 10.7326/0003-4819-106-4-546 Jacobson, 1988, Cholestasis and disseminated cytomegalovirus disease in patients with the acquired immunodeficiency syndrome, Am J Med, 84, 218, 10.1016/0002-9343(88)90417-2 Post, 1986, Cytomegalic inclusion virus encephalitis in patients with AIDS: CT, clinical and pathologic correlation, Am J Radiol, 146, 1229 Said, 1991, Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study, Ann Neurol, 29, 139, 10.1002/ana.410290205 Mills, 1988, Treatment of cytomegalovirus retinitis in patients with AIDS, Rev Infect Dis, 10, S522, 10.1093/clinids/10.Supplement_3.S522 Jabs, 1987, Treatment of cytomegalovirus retinitis with ganciclovir, Ophthalmology, 94, 824, 10.1016/S0161-6420(87)33535-3 Jacobson, 1988, Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis, J Med Virol, 25, 339, 10.1002/jmv.1890250311 Sha, 1991, Suppression of cytomegalovirus retinitis in persons with AIDS with high dose intravenous acyclovir, J Infect Dis, 164, 777, 10.1093/infdis/164.4.777 Fanning, 1990, Foscarnet therapy of cytomegalovirus retinitis in AIDS, J Acquir Immune Defic Syndr, 3, 472, 10.1097/00126334-199005000-00002 Jacobson, 1989, Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome, Antimicrob Agents Chemother, 33, 736, 10.1128/AAC.33.5.736 Jacobson, 1991, Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS, J Infect Dis, 163, 1348, 10.1093/infdis/163.6.1348 Dietrich, 1990, Randomized, placebo-controlled study of ganciclovir treatment of cytomegalovirus (CMV) colitis in AIDS patients, 113 Nelson, 1991, Foscarnet in the treatment of cytomegalovirus infection of the esophagus and colon in patients with acquired immune deficiency syndrome, Am J Gastroenterol, 86, 876 Hochster, 1990, Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS, Ann Intern Med, 113, 111, 10.7326/0003-4819-113-2-111 van der Wouw, 1991, Effect of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS-related complex, a phase I/II study, Br J Haematol, 78, 319, 10.1111/j.1365-2141.1991.tb04443.x Jabs, 1991 Erlich, 1989, Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome, N Engl J Med, 320, 293, 10.1056/NEJM198902023200506 Erlich, 1989, Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS), 110, 710 Safrin, 1990, Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: Preliminary data, J Infect Dis, 161, 1078, 10.1093/infdis/161.6.1078 Engel, 1990, Treatment of resistant herpes simplex virus with continuous-infusion acyclovir, JAMA, 263, 1662, 10.1001/jama.1990.03440120084042 Safrin, 1991, A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome, N Engl J Med, 325, 551, 10.1056/NEJM199108223250805 Weaver, 1991, Topical trifluridine (TFT) treatment of acyclovir-resistant (ACV-R) herpes simplex disease, 183 Friedman-Kien, 1986, Herpes zoster: A possible early clinical sign for development of acquired immunodeficiency syndrome in high risk individuals, J Am Acad Dermatol, 14, 1023, 10.1016/S0190-9622(86)70127-8 Melbye, 1987, Risk of AIDS after herpes zoster, Lancet, 1, 728, 10.1016/S0140-6736(87)90365-5 Cohen, 1988, Disseminated herpes zoster in patients with human immunodeficiency virus infection, Am J Med, 84, 1076, 10.1016/0002-9343(88)90315-4 Jacobson, 1990, Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS), Ann Intern Med, 112, 187, 10.7326/0003-4819-112-3-187 Safrin, 1991, Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection, Ann Intern Med, 115, 19, 10.7326/0003-4819-115-1-19 Greenspan, 1985, Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS associated lesion, N Engl J Med, 313, 1564, 10.1056/NEJM198512193132502 Eversole, 1988, Detection of EBV and HVP DNA sequences in oral “hairy” leukoplakia by in situ hybridization, J Med Virol, 26, 271, 10.1002/jmv.1890260307 Resnick, 1988, Regression of oral hairy leukoplakia after orally administered acyclovir therapy, JAMA, 259, 384, 10.1001/jama.1988.03720030044031 Kessler, 1988, Regression of oral hairy leukoplakia during zidovudine therapy, Arch Intern Med, 148, 2496, 10.1001/archinte.1988.00380110124026 Newman, 1987, Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl) guanine (DHPG), Ann Intern Med, 107, 348, 10.7326/0003-4819-107-2-348 Kaplan, 1989, AIDS-associated non-Hodgkin's lymphoma in San Francisco, JAMA, 261, 719, 10.1001/jama.1989.03420050069041 Levine, 1987, Non-Hodgkin's lymphomas and other malignancies in the acquired immune deficiency syndrome, Semin Oncol, 14, 34 Bermudez, 1989, Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome: Indications for intensive chemotherapy, Am J Med, 86, 71, 10.1016/0002-9343(89)90232-5 Cobb, 1990, Human papillomavirus infection, J Am Acad Dermatol, 22, 547, 10.1016/0190-9622(90)70073-Q Palefsky, 1990, Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease, JAMA, 263, 2911, 10.1001/jama.1990.03440210061033 Henry, 1989, Association of human immunodeficiency virus-induced immunosuppression with human papillomavirus infection and cervical intraepithelial neoplasia, Am J Obstet Gynecol, 160, 352, 10.1016/0002-9378(89)90441-9 Centers for Disease Control, 1990, Risk for cervical disease in HIV-infected women—New York City, MMWR, 39, 846 Minkoff, 1991, Care of women infected with the human immunodeficiency virus, JAMA, 266, 2253, 10.1001/jama.1991.03470160085037 Houff, 1988, Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy, N Engl J Med, 318, 301, 10.1056/NEJM198802043180507 Berger, 1987, Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection, 107, 78 Conway, 1990, Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: Apparent response to 3′-azido-3′-deoxythymidine, Rev Infect Dis, 12, 479, 10.1093/clinids/12.3.479 Chaisson, 1990, Progressive multifocal leukoencephalopathy in AIDS, JAMA, 264, 79, 10.1001/jama.1990.03450010083036 Goodman, 1987, Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex, J Am Acad Dermatol, 17, 210, 10.1016/S0190-9622(87)70193-5 Cortes, 1989, HIV-1, HIV-2, and HTLV-I infection in high risk groups in Brazil, N Engl J Med, 320, 953, 10.1056/NEJM198904133201501 Wiley, 1989, HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus, N Engl J Med, 320, 992, 10.1056/NEJM198904133201507 Shibata, 1989, Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type I (HIV-I), Ann Intern Med, 111, 871, 10.7326/0003-4819-111-11-871 Redfield, 1987, Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease, N Engl J Med, 316, 673, 10.1056/NEJM198703123161106 Dorozynski, 1991, Deaths in vaccine trials trigger French inquiry news, Science, 252, 501, 10.1126/science.2020851 Cunningham, 1988, Gastrointestinal viral infections in homosexual men who were symptomatic and seropositive for human immunodeficiency virus, J Infect Dis, 158, 386, 10.1093/infdis/158.2.386 Janner, 1990, Fatal adenovirus infection in a child with acquired immunodeficiency syndrome, Pediatr Infect Dis J, 9, 434, 10.1097/00006454-199006000-00013 Horsburgh, 1989, The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS), Am Rev Respir Dis, 139, 4, 10.1164/ajrccm/139.1.4 Young, 1988, Mycobacterium avium complex infection, J Infect Dis, 157, 863, 10.1093/infdis/157.5.863 Walch, 1984, Autopsy findings in the acquired immune deficiency syndrome, JAMA, 252, 1152, 10.1001/jama.1984.03350090028018 Horsburgh, 1991, Mycobacterium avium complex infection in the acquired immunodeficiency syndrome, N Engl J Med, 324, 1332, 10.1056/NEJM199105093241906 Ellner, 1991, Mycobacterium avium infection and AIDS: A therapeutic dilemma in rapid evolution, J Infect Dis, 163, 1326, 10.1093/infdis/163.6.1326 Shanson, 1988, Comparison of methods for isolating Mycobacterium avium-intracellulare from blood of patients with AIDS, J Clin Pathol, 41, 687, 10.1136/jcp.41.6.687 Benson, 1990, Treatment of AIDS-related disseminated Mycobacterium avium complex disease (D-MAC) with a multiple drug regimen including amikacin, 251 Benson, 1991, Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin, Arch Intern Med, 151, 582, 10.1001/archinte.1991.00400030116021 Hoy, 1990, Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients, J Infect Dis, 161, 801, 10.1093/infdis/161.4.801 Chiu, 1990, Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin, Ann Intern Med, 113, 358, 10.7326/0003-4819-113-5-358 Dautzenberg, 1991, Activity of clarithromycin against Mycobacterium avium infections in patients with the acquired immunodeficiency syndrome, 144, 564 Young, 1991, Azithromycin reduces M. avium complex (MAC) bacteremia and relieves its symptoms in patients with AIDS, 148 Centers for Disease Control, 1987, Tuberculosis and acquired immunodeficiency syndrome—New York City, MMWR, 36, 785 Centers for Disease Control, 1990, Screening for tuberculosis and tuberculous infection in high-risk populations and the use of preventive therapy for tuberculous infection in the United States, 39, 1 Centers for Disease Control, 1991, Purified protein derivative (PPD)-tuberculin anergy and HIV infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis, MMWR, 40, 27 Small, 1991, Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection, N Engl J Med, 324, 289, 10.1056/NEJM199101313240503 Sherer, 1986, Disseminated infection with Mycobacterium kansasii in the acquired immunodeficiency syndrome, Ann Intern Med, 105, 710, 10.7326/0003-4819-105-5-710 Levine, 1991, Mycobacterium kansasii: A cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection, Ann Intern Med, 114, 861, 10.7326/0003-4819-114-10-861 Samaryanayake, 1989, Oral candidiasis and human immunodeficiency virus infection, J Oral Pathol Med, 18, 554, 10.1111/j.1600-0714.1989.tb01552.x Imam, 1990, Hierarchical pattern of mucosal candida infections in HIV-seropositive women, Am J Med, 89, 142, 10.1016/0002-9343(90)90291-K Carpenter, 1989, Natural history of acquired immunodeficiency syndrome in women in Rhode Island, Am J Med, 86, 771, 10.1016/0002-9343(89)90471-3 Lake-Bakaar, 1988, Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS), Ann Intern Med, 109, 471, 10.7326/0003-4819-109-6-471 Luger, 1986, Cryptococcal disease in patients with the acquired immunodeficiency syndrome, 104, 234 Chuck, 1989, Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome, N Engl J Med, 321, 794, 10.1056/NEJM198909213211205 Bozzette, 1991, Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS, Ann Intern Med, 115, 285, 10.7326/0003-4819-115-4-285 Sugar, 1990, Overview: Treatment of cryptococcal meningitis, Rev Infect Dis, 12, S338, 10.1093/clinids/12.Supplement_3.S338 Larsen, 1990, Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS, 113, 183 Bozzette, 1991, A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome, N Engl J Med, 324, 580, 10.1056/NEJM199102283240902 Sugar, 1988, Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome, Am J Med, 85, 481, 10.1016/S0002-9343(88)80082-2 Graybill, 1988, Histoplasmosis and AIDS, J Infect Dis, 158, 623, 10.1093/infdis/158.3.623 Wheat, 1990, Disseminated histoplasmosis in the acquired immune deficiency syndrome: Clinical findings, diagnosis, and treatment, and review of the literature, Medicine, 69, 361, 10.1097/00005792-199011000-00004 Wheat, 1989, Histoplasma capsulatum polysaccharide antigen detection in diagnosis and management of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome, Am J Med, 87, 396, 10.1016/S0002-9343(89)80820-4 McKinsey, 1989, Long-term amphotericin B therapy for disseminated histoplasmosis in patients with acquired immunodeficiency syndrome (AIDS), Ann Intern Med, 111, 655, 10.7326/0003-4819-111-8-655 Sharkey, 1991, High dose itraconazole in the treatment of severe mycoses, Antimicrob Agents Chemother, 35, 707, 10.1128/AAC.35.4.707 Pottage, 1991, Development of histoplasmosis in an HIV infected patient receiving fluconazole, J Infect Dis, 164, 622, 10.1093/infdis/164.3.622 Bronnimann, 1987, Coccidioidomycosis in the acquired immunodeficiency syndrome, Ann Intern Med, 106, 372, 10.7326/0003-4819-106-3-372 Denning, 1991, Pulmonary aspergillosis in the acquired immunodeficiency syndrome, N Engl J Med, 324, 654, 10.1056/NEJM199103073241003 Polsky, 1986, Bacterial pneumonia in patients with the acquired immunodeficiency syndrome, Ann Intern Med, 104, 38, 10.7326/0003-4819-104-1-38 Witt, 1987, Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex, Am J Med, 82, 900, 10.1016/0002-9343(87)90150-1 Krumholz, 1989, Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: Clinical presentation, bacteriology, and outcome, Am J Med, 86, 776, 10.1016/0002-9343(89)90472-5 Celum, 1987, Incidence of salmonellosis in patients with AIDS, J Infect Dis, 156, 998, 10.1093/infdis/156.6.998 Perlman, 1988, Persistent Campylobacter jejuni infection in patients infected with human immunodeficiency virus (HIV), Ann Intern Med, 108, 540, 10.7326/0003-4819-108-4-540 Hoegsberg, 1990, Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease, Am J Obstet Gynecol, 163, 1135, 10.1016/0002-9378(90)90671-S Koehler, 1988, Cutaneous vascular lesions and disseminated cat-scratch disease in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, Ann Intern Med, 109, 449, 10.7326/0003-4819-109-6-449 Relman, 1990, The agent of bacillary angiomatosis, 323, 1573 Perkocha, 1990, Clinical and pathologic features of bacillary peliosis hepatis in association with human immunodeficiency virus infection, N Engl J Med, 323, 1581, 10.1056/NEJM199012063232302 Kramer, 1990, The radiographic appearance of pulmonary nocardiosis associated with AIDS, Chest, 98, 382, 10.1378/chest.98.2.382 Kales, 1990, Listeriosis in patients with HIV infection: Clinical manifestations and response to therapy, J Acquir Immune Defic Syndr, 3, 139 Khardori, 1987, Legionella micdadei pneumonia in the acquired immune deficiency syndrome, letter, Am J Med, 83, 600, 10.1016/0002-9343(87)90783-2 Hook, 1989, Syphilis and HIV infection, J Infect Dis, 160, 530, 10.1093/infdis/160.3.530 Johns, 1987, Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus, N Engl J Med, 316, 1569, 10.1056/NEJM198706183162503 Musher, 1990, Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment, Ann Intern Med, 113, 872, 10.7326/0003-4819-113-11-872 Rutherford, 1989, The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco, J Infect Dis, 159, 569, 10.1093/infdis/159.3.569 Lassoued, 1991, AIDS-associated Kaposi's sarcoma in female patients, AIDS, 5, 877, 10.1097/00002030-199107000-00013 Northfelt, 1991, Treatment of AIDS-related Kaposi's sarcoma, Hematol Oncol Clin North Am, 5, 297, 10.1016/S0889-8588(18)30442-8 Krown, 1991, Interferon and other biologic agents for the treatment of Kaposi's sarcoma, Hematol Oncol Clin North Am, 5, 311, 10.1016/S0889-8588(18)30443-X Gill, 1991, Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial, Am J Med, 90, 427, 10.1016/0002-9343(91)80081-V Bashir, 1989, Detection of Epstein-Barr virus in CNS lymphomas by in-situ hybridization, Neurology, 39, 813, 10.1212/WNL.39.6.813 Goldstein, 1991, Primary central nervous system lymphoma in acquired immune deficiency syndrome, 67, 2756 Harnly, 1988, Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS), Am J Epidemiol, 128, 261, 10.1093/oxfordjournals.aje.a114966 Sariban, 1983, Central nervous system involvement in American Burkitt's lymphoma, J Clin Oncol, 1, 677, 10.1200/JCO.1983.1.11.677 Nasr, 1988, Peripheral T-cell lymphoma in a patient with acquired immuno-deficiency syndrome, Cancer, 61, 947, 10.1002/1097-0142(19880301)61:5<947::AID-CNCR2820610515>3.0.CO;2-G Gupta, 1987, Malignant melanoma in a homosexual man with HTLV-HI/LAV exposure, Am J Med, 83, 1027, 10.1016/0002-9343(87)90169-0 Gold, 1991, HIV-associated Hodgkin's disease: A clinical study of 18 cases and review of the literature, Am J Hematol, 36, 93, 10.1002/ajh.2830360205